ChaosBio Deal 1 a Series of CGF2021 LLC is conducting a $43,000 exempt securities offering to cover fund organizational and operating expenses. The notice identifies the entity as a Venture Capital pooled Investment fund and names Chao Zheng as manager, giving investors the stated use and structure of the capital.
Key Highlights
- The entity is classified as a pooled investment fund and venture capital fund.
- Proceeds are designated for fund organizational and operating expenses.
- Chao Zheng is identified as manager, while ChaosBio Management is listed as executive officer.
ChaosBio Deal 1 a Series of CGF2021 LLC has a $43,000 exempt securities offering designated for fund organizational and operating expenses. The notice identifies the entity as a Delaware Limited Liability company and a venture capital fund.
$43,000 Offering Covers Fund Costs
The offering is described as an exempt securities offering, with $43,000 attributed to the fund’s organizational and operating expenses. Its listed address is 2093 Philadelphia Pike, 5885, Claymont, Delaware 19,703. Chao Zheng signed for the entity as manager on September 9, 2026. The notice identifies the entity as an LLC organized in Delaware.
FAQs
Q: What is the ChaosBio Deal 1 $43,000 offering for?
A: The exempt securities offering is intended to cover organizational and operating expenses for ChaosBio Deal 1 a Series of CGF2021 LLC, which is classified as a venture capital fund.
Q: What type of entity is ChaosBio Deal 1 a Series of CGF2021 LLC?
A: ChaosBio Deal 1 a Series of CGF2021 LLC is a Delaware limited liability company classified as a pooled investment fund and venture capital fund.
Q: Who manages ChaosBio Deal 1 a Series of CGF2021 LLC?
A: Chao Zheng is identified as manager and signed for the entity on September 9, 2026. ChaosBio Management is listed as executive officer.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.